Risk factors and guideline adherence of empiric antibiotic use in community-acquired pneumonia
S. Pascual Guardia (Barcelona, Spain), J. Marin-Corral (Barcelona, Spain), F. Amati (Milano, Italy), S. Aliberti (Milano, Italy), M. Carugati (Milano, Italy), O. Sibila (Barcelona, Spain), F. Sanz (Valencia, Spain), A. Rodriguez (Tarragona, Spain), G. Sotgiu (Sassari, Italy), P. Marcos (A.Coruña, Spain), M. Restrepo (San Antonio, United States), .. On Behalf Of Glimp Investigators (San Antonio, United States)
Source: International Congress 2022 – COPD management: comorbidities, cohorts and real-world studies
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Pascual Guardia (Barcelona, Spain), J. Marin-Corral (Barcelona, Spain), F. Amati (Milano, Italy), S. Aliberti (Milano, Italy), M. Carugati (Milano, Italy), O. Sibila (Barcelona, Spain), F. Sanz (Valencia, Spain), A. Rodriguez (Tarragona, Spain), G. Sotgiu (Sassari, Italy), P. Marcos (A.Coruña, Spain), M. Restrepo (San Antonio, United States), .. On Behalf Of Glimp Investigators (San Antonio, United States). Risk factors and guideline adherence of empiric antibiotic use in community-acquired pneumonia. 2114
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|